185
Volume 5, Issue 10: Special Issue
(EJAR)
ISSN: 2181-2020
MPHAPP
THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL
CONFERENCE
“
MODERN PHARMACEUTICS: ACTUAL
PROBLEMS AND PROSPECTS
”
TASHKENT, OCTOBER 17, 2025
in-academy.uz
ASSORTMENT ANALYSIS OF HORMONAL DRUGS REGISTERED IN THE
REPUBLIC OF UZBEKISTAN
Ergasheva G.Q.
Raximov A.A.
Institute of Pharmaceutical Education and research, Tashkent City, Republic of Uzbekistan
e-mail: gulzoda1999a@mail.ru
https://doi.org/10.5281/zenodo.17332605
Relevance:
hormones are important for a person to lead an active life. Hormones regulate all
the processes that go in the div, support its stability, respond to external and internal changes, while
controlling reproductive health and growth. If the hormonal balance fails, it leads to negative
consequences such as stress, fatigue, changes in weight, metabolic disorders.elevance: hormones are
important for a person to lead an active life. Hormones regulate all the processes that go in.
Purpose of the study:
analysis of hormonal drugs based on the State Register of medicines and
medical products registered in the Republic of Uzbekistan.
Materials and methods:
on the basis of the State Register of medicines and medical products
registered in the Republic of Uzbekistan, an assortment analysis of hormonal drugs was carried out
using qualimetric methods.
Results:
during the research, an analysis was carried out on the total amount, width, depth and
renewal indicator of hormonal drugs allowed for use in the CIS countries, in the Republic and abroad,
and hormonal drugs registered in the Republic of Uzbekistan were studied between 2020 and 2024.
According to this, in 2020, it was found that hormonal drugs produced by domestic manufacturers
accounted for 20%, the CIS countries accounted for 27.37%, and hormonal drugs produced by foreign
manufacturers accounted for 52.63%.ccording to this, in 2020, it was found that hormonal drugs
produced by domestic manufacturers accounted for 20%, the CIS countries accounted for 27.37%,
and hormonal drugs produced by foreign manufacturers accounted for 52.63%. And in 2024,
hormonal drugs produced by domestic manufacturers accounted for 28.23%, the CIS countries
accounted for 16.13%, and hormonal drugs produced by foreign manufacturers accounted for
55.65%. During the analysis, an analysis was carried out on the depth indicator of hormonal drugs
registered in the Republic of Uzbekistan in 2024. In this, the CIS countries accounted for 10%, in the
foreign countries this figure was 4.35%. At the next stage of the analysis, an analysis was carried out
on the hormonal drug renewal index.uring the analysis, an analysis was carried out on the depth
indicator of hormonal drugs registered in the Republic of Uzbekistan in 2024.
Conclusions:
as of 2024, the pharmaceutical market of Uzbekistan has been found to contain
hormonal drugs with 124 different trade names. The bulk of hormonal drugs in the pharmaceutical
market-55.65% - are drugs imported from foreign countries or manufactured there.
